Hualan Biotech (002007.SZ) shares company dupliumab injection clinical trial application accepted

Zhitongcaijing · 1d ago

Zhitong Finance App News, Hualan Biotech (002007.SZ) issued an announcement. Recently, Hualan Ankang Biology Co., Ltd., the company's shareholding company, received a “Notice of Acceptance” issued by the State Drug Administration for the registration of a clinical trial application for dupriumab injections produced domestically. The drug is indicated for atopic dermatitis, asthma, prurigo nodular, chronic obstructive pulmonary disease, and bullous pemphigoid.